The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort.
Stahl M, DeVeaux M, de Witte T, Neukirchen J, Sekeres MA, Brunner AM, Roboz GJ, Steensma DP, Bhatt VR, Platzbecker U, Cluzeau T, Prata PH, Itzykson R, Fenaux P, Fathi AT, Smith A, Germing U, Ritchie EK, Verma V, Nazha A, Maciejewski JP, Podoltsev NA, Prebet T, Santini V, Gore SD, Komrokji RS, Zeidan AM.
Stahl M, et al. Among authors: neukirchen j.
Blood Adv. 2018 Jul 24;2(14):1765-1772. doi: 10.1182/bloodadvances.2018019414.
Blood Adv. 2018.
PMID: 30037803
Free PMC article.
Clinical Trial.